Mereo BioPharma Group PLC ADR

Quarterly Financials

Values in thousands 2024-06-30 2024-03-31 2023-12-31 2023-09-30
Revenue
$0
$0
$361
$533
Gross Profit
-257
-274
144
360
EBITDA
-12,571
-9,900
-5,504
-5,966
EBIT
-12,828
-10,174
-5,744
-6,209
Net Income
-12,268
-8,951
-6,046
-6,559
Net Change In Cash
0
0
361
533
Free Cash Flow
-7,913
-8,686
-1,704
-2,474
Cash
87,431
48,660
57,421
47,065
Basic Shares
142,354
700,263
691,820
691,820

Annual Financials

Values in thousands 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Revenue
$10,000
$1,507
$36,464
$393
Gross Profit
7,426
571
18,556
-15,954
EBITDA
-23,954
-42,062
-20,314
-37,525
EBIT
-25,015
-43,569
-21,180
-37,569
Net Income
-29,466
-34,196
12,725
-163,628
Net Change In Cash
10,000
1,507
36,464
393
Free Cash Flow
-21,551
-38,830
-5,774
-28,357
Cash
57,421
56,334
94,296
23,469
Basic Shares
659,453
603,196
555,275
338,953

Earnings Calls

Quarter EPS
2024-06-30
-$0.08
2024-03-31
-$0.06
2023-09-30
$0
2023-06-30
-$0.02